Orphan Drugs:A Challenge for the Pharmaceutical Industry in Europe - Hagn, Daniel
Expédition rapide et soignée depuis l`Angleterre - Délai de livraison: entre 10 et 20 jours ouvrés.
- Payez directement sur Rakuten (CB, PayPal, 4xCB...)
- Récupérez le produit directement chez le vendeur
- Rakuten vous rembourse en cas de problème
Gratuit et sans engagement
Félicitations !
Nous sommes heureux de vous compter parmi nos membres du Club Rakuten !
TROUVER UN MAGASIN
Retour
Avis sur Orphan Drugs:A Challenge For The Pharmaceutical Industry In Europe de Hagn, Daniel - Livre Anglais
0 avis sur Orphan Drugs:A Challenge For The Pharmaceutical Industry In Europe de Hagn, Daniel - Livre Anglais
Les avis publiés font l'objet d'un contrôle automatisé de Rakuten.
-
Catafalque
Neuf dès 86,94 €
-
Les Chevaux De La Satire - Les Koredugaw Du Mali
1 avis
Occasion dès 41,70 €
-
English Legal System Eighth Edition
Neuf dès 60,59 €
-
Turc Sans Peine Méthode Assimil
Occasion dès 60,25 €
-
Love On The Left Bank
2 avis
Neuf dès 43,77 €
Occasion dès 31,62 €
-
Stalky Et Cie Fo Bi
Occasion dès 30,80 €
-
The Chemistry Between Us
Neuf dès 40,66 €
-
The Work Of Hipgnosis -Walk Away Rene
1 avis
Occasion dès 71,99 €
-
Beauty Imagined: A History Of The Global Beauty Industry
Occasion dès 33,93 €
-
The Collected Poems Of Amy Clampitt
Neuf dès 49,38 €
-
Trinity: Le Secret Le Mieux Gardé
1 avis
Occasion dès 53,00 €
-
Options As A Strategic Investment
Neuf dès 34,83 €
-
Sf2a : Scientific Highlights 2004
Occasion dès 69,00 €
-
Diagrammatic Chart Of World History 5000 Years Of History
Occasion dès 29,90 €
-
Sviatoslav Richter
1 avis
Neuf dès 29,71 €
-
Les Clés De L'allemand D'aujourd'hui - 408 Repères Grammaticaux
2 avis
Occasion dès 37,00 €
-
Le Corbusier
2 avis
Neuf dès 445,67 €
Occasion dès 59,90 €
-
Savage Detectives
Neuf dès 32,42 €
-
Best-Kept Boy In The World
Neuf dès 35,65 €
-
Belle Du Seigneur: A Novel
Occasion dès 34,89 €
Produits similaires
Présentation Orphan Drugs:A Challenge For The Pharmaceutical Industry In Europe de Hagn, Daniel
- Livre Anglais
Résumé :
The promotion and development of medicinal products for the treatment of rare diseases require our particular attention, as health is our most valuable possession, said Ursula Schleicher, former Vice-President of the European Parliament. According to estimates, around 25 million people in Europe are suffering from 5,000 to 8,000 orphan diseases. Many of them are still waiting for medicines that will allow them to at least be able to lead a pain-free life, if not always a normal life. From a purely business-management viewpoint, the development of drugs for rare diseases is not always economical for the pharmaceutical industry. Nor can sufferers raise the funds themselves for research into the drugs that for them are vitally necessary. It is, therefore, a question of moral values and national priorities as to what extent society is prepared to help those affected. In 1999 the European Union adopted the Orphan Medicinal Products Regulation. This offers the biopharmaceutical and pharmaceutical industry incentives to develop orphan drugs. This book presents the European Orphan Medicinal Products Regulation and compares it with the rules of other countries. It also discusses the possibilities of creating further incentives....
Détails de conformité du produit
Personne responsable dans l'UE